MedPath

DEsflurane Versus Isoflurane for inhaLation sedation of critically ill patients

Conditions
Sedation of ventilated patients
Registration Number
DRKS00011403
Lead Sponsor
niversitätsklinikum des Saarlandes
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
21
Inclusion Criteria

Age >= 18 years and expected time of invasive ventilation and sedation >24 hours

Exclusion Criteria

sedation > 48 hours before start of study medication.
contra indications for administration of volatile anaesthetics (pregnancy, malignant hyperthermia)
tidal volume < 300 ml (< 200 ml if ECMO is used)
severe acute neurological illness,
head injury with significant intracranial bleeding,
high probability of diffuse axonal injury because of trauma mechanism or other accompagning injuries,
poor prognosis (expected survival time < 24 hours),
inability to follow simple verbal commands (before ICU stay)
history of deafness,
history of malignant hyperthermia of the patient or her/his Family.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Context sensitive half time, i.e. time until the concentration of the volatile anaesthetic in the expired air has decreased to 50% of baseline, measured in a sedation window (awakening test).
Secondary Outcome Measures
NameTimeMethod
80% decrement time (time until the concentration of the volatile anaesthetic in the expired air has decreased to 20% of baseline);<br>time to first eye opening,<br>time to first Hand grip on command,<br>time to first movement of a specified extremity on command,<br>time to Narcotrend Stadium A (electroencephalographic anaesthesia Monitor)<br>percentage of time when the Patient was breathing spontaneously.
© Copyright 2025. All Rights Reserved by MedPath